Clolar and renal failure Patient Reports February 13, 2012

Clolar Side Effects Report #5683311-1
Clolar side effect was reported by a Physician from UNITED STATES on Mar 21, 2008. Female patient, 65 years of age, was diagnosed with lymphoma  and was treated with Clolar. After drug was administered, patient experienced the following side effects: anaemia, neutropenia, renal failure, thrombocytopenia. Clolar dosage: unknown. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6121672-X
Clolar side effect was reported by a Physician from UNITED STATES on Mar 05, 2009. Female patient was diagnosed with haematological malignancy and was treated with Clolar. After drug was administered, patient experienced the following side effects: graft versus host disease, mucosal inflammation, nephropathy toxic, pulmonary haemorrhage, renal failure, therapeutic agent toxicity. Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.

Clolar Side Effects Report #6125040-6
Clolar side effect was reported by a Physician from UNITED STATES on Mar 05, 2009. Female patient was diagnosed with haematological malignancy and was treated with Clolar. After drug was administered, patient experienced the following side effects: mucosal inflammation, nephropathy toxic, pulmonary haemorrhage, renal failure, therapeutic agent toxicity. Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.

Clolar Side Effects Report #5480410-4
Clolar side effect was reported by a Pharmacist from UNITED STATES on Oct 04, 2007. Female patient, 47 years of age, weighting 185.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Clolar. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, blood culture positive, candidiasis, ejection fraction decreased, febrile neutropenia, hyperbilirubinaemia, nephrotic syndrome, renal failure, respiratory distress. Clolar dosage: 81MG QD X5 DAYS IV. Patient was hospitalized. Patient recovered.


Clolar Side Effects Report #5583909-5
Clolar side effect was reported by a Physician from UNITED STATES on Dec 28, 2007. Male patient, 55 years of age, weighting 162.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: dysphagia, febrile neutropenia, haemoglobin decreased, pericardial effusion, platelet count decreased, renal failure, staphylococcal abscess, staphylococcal bacteraemia, tongue abscess. Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5720929-1
Clolar side effect was reported by a Physician from UNITED STATES on Apr 21, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: dialysis , enterococcal infection, hypoxia, neutropenic infection, refusal of treatment by relative, renal failure, respiratory failure, sepsis , staphylococcal infection . Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 04/08/2008.

Clolar Side Effects Report #5738493-X
Clolar side effect was reported by a Physician from UNITED STATES on May 07, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: culture urine positive, dialysis , enterococcal infection, hypoxia, neutropenic infection, renal failure, respiratory failure, sepsis syndrome, staphylococcal infection . Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, CALCIUM ACETATE, DEXAMETHASONE PHOSPHATE, FLUCONAZOLE, ACETAMINOPHEN, ACYCLOVIR, ESCITALOPRAM. Patient died on 04/08/2008.

Clolar Side Effects Report #5764138-9
Clolar side effect was reported by a Physician from UNITED STATES on May 30, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: culture urine positive, dialysis , enterococcal infection, enterococcal sepsis, neutropenic sepsis, renal failure, respiratory failure, staphylococcal infection , staphylococcal sepsis. Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, CALCIUM ACETATE, DEXAMETHASONE PHOSPHATE, FLUCONAZOLE, ACETAMINOPHEN, ACYCLOVIR, ALBUTEROL SULPHATE, ESCITALOPRAM OXALATE. Patient died on 04/08/2008.

Clolar Side Effects Report #5989892-2
Clolar side effect was reported by a Physician from SINGAPORE on Nov 25, 2008. Female patient, 35 years of age, weighting 231.5 lb, was diagnosed with acute leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: hyperbilirubinaemia, mucosal inflammation, multi-organ failure, pyrexia, renal failure, vomiting. Clolar dosage: 22.5 MG/M2, QDX5,. During the same period patient was treated with IDARUBICIN, CYTARABINE. Patient died on 11/08/2008.


Clolar Side Effects Report #5714026-9
Clolar side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 22, 2008. Male patient, weighting 136.7 lb, was treated with Clolar. After drug was administered, patient experienced the following side effects: dialysis , enterococcal infection, renal failure, respiratory failure, staphylococcal infection . Clolar dosage: 352 MG. During the same period patient was treated with CYTARABINE. Patient died.